WO2022037242A1 - Valve stent and prosthetic heart valve - Google Patents

Valve stent and prosthetic heart valve Download PDF

Info

Publication number
WO2022037242A1
WO2022037242A1 PCT/CN2021/101409 CN2021101409W WO2022037242A1 WO 2022037242 A1 WO2022037242 A1 WO 2022037242A1 CN 2021101409 W CN2021101409 W CN 2021101409W WO 2022037242 A1 WO2022037242 A1 WO 2022037242A1
Authority
WO
WIPO (PCT)
Prior art keywords
valve
support
segment
section
leaflet
Prior art date
Application number
PCT/CN2021/101409
Other languages
French (fr)
Chinese (zh)
Inventor
赖柳山
陈文俊
郑伟城
Original Assignee
先健科技(深圳)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 先健科技(深圳)有限公司 filed Critical 先健科技(深圳)有限公司
Publication of WO2022037242A1 publication Critical patent/WO2022037242A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents

Definitions

  • the invention belongs to the technical field of medical devices, and in particular relates to a valve support and an artificial heart valve.
  • the main function of the human heart is to provide power for the blood in the human body.
  • the heart is anatomically divided into: right atrium, right ventricle, left atrium, and left ventricle. Blood flows from the superior vena cava and inferior vena cava into the right atrium, then through the tricuspid valve into the right ventricle, where blood flows through the pulmonary valve into the lungs under the action of right ventricular contraction. The blood flows into the left atrium after being exchanged for oxygen in the lungs, and then flows into the left ventricle through the mitral valve.
  • There are four valves in the human heart namely the tricuspid valve, the pulmonary valve, the mitral valve and the aortic valve.
  • the tricuspid valve is located between the right atrium and the right ventricle; the mitral valve is located between the left atrium and the left ventricle.
  • Naturally formed normal valves generally have two or three leaflets, and the roots of the leaflets are fixed on the valve annulus; the free edges of the leaflets have no other structures or are connected with chordae tendineae, and the other end of the chordae tendineae is connected to the papilla on the myocardial wall. on the muscle.
  • the function of the valve is to restrict the direction of blood flow. When the valve leaflet is open, it allows blood to flow from the inflow end to the outflow end of the valve, and when the valve leaflet is closed, it prevents blood from flowing from the outflow end to the inflow end of the valve.
  • All four valves are located at the entrance and exit of the ventricle.
  • the tricuspid and mitral valves open, the pulmonary and aortic valves close, and blood flows from the atrium into the ventricle; when the ventricle contracts, the tricuspid and mitral valves The valves close, the pulmonary and aortic valves open, and blood flows from the ventricles into the arteries. It can be seen that whether the opening and closing function of the valve is normal will directly affect whether the heart function of the human body can provide power for the blood normally.
  • heart valve disease has become one of the common cardiovascular diseases, and its pathological changes are mainly valvular insufficiency.
  • the cause it can be divided into two categories: the first type is organic, which is due to the organic nature of the valve leaflets themselves.
  • the main causes are congenital malformation or defect of the valve, rheumatic valve disease, calcification, etc.; the second category is functional, the valve itself has no organic disease, mainly due to indirect causes such as atrial enlargement and high pressure. Spatial abnormalities of papillary muscles, chordae tendineae, myocardial wall, etc.
  • interventional heart valve stents have begun to be used in aortic valve, pulmonary valve, mitral valve, tricuspid valve and other cases that are not suitable for surgical operations. It is growing rapidly, and multiple clinical trials are also underway. The results of the trials will provide more evidence-based medical evidence for the application of this technology.
  • the purpose of the present invention is to at least solve the problem of insufficiency and excessive central regurgitation caused by the influence of the shape of the target position on the opening and closing effect of the valve leaflet when the stent is implanted at the target position.
  • a first aspect of the present invention provides a valve support, the valve support has a tubular structure, the valve support includes a support section, a transition section and a valve leaflet section, and the transition section is used to connect the support section and the valve support section.
  • the valve leaflet segment, the valve leaflet segment is used for setting the valve leaflet
  • the support segment is used for supporting the valve support
  • the maximum diameter of the valve leaflet segment is smaller than the maximum diameter of the transition segment
  • the transition segment has a maximum diameter.
  • the maximum diameter is smaller than or equal to the maximum diameter of the support section, wherein the transition section includes several connecting rods, and the connecting rods form at least one open structural unit on the transition section.
  • valve leaflet segment by providing a support segment, a transition segment and a valve leaflet segment, the valve leaflet segment is provided with valve leaflets, the support segment is used to support the entire valve stent, and the maximum diameter of the transition segment is smaller than or equal to the maximum diameter of the support segment. , so that the support segment can be supported at the target position for fitting, and the maximum diameter of the valve leaflet segment is smaller than the maximum diameter of the transition segment.
  • the valve leaflet segment provided with the valve leaflet does not need to be completely fitted The target position, so the leaflet segment provided with the leaflet is not easily affected by the shape of the target position, and the problems of insufficiency and excessive central regurgitation occur.
  • the transition section is used to connect the support section and the leaflet section, and the transition section includes several connecting rods.
  • the connecting rods form an open structural unit on the transition section, so that the radial stiffness of the transition section is reduced, so that the support sections connected at both ends of the transition section are connected. and the valve leaflet segment can be unaffected by each other, which is beneficial to block the radial force transmission from the support segment to the valve leaflet segment, so that during the release process, the valve leaflet segment or the support segment can be completely released first, while the other segment is retained in the delivery sheath. It is beneficial to select the most suitable state for release during use, reducing the difficulty of operation.
  • valve stent according to the present invention may also have the following additional technical features:
  • the radial stiffness of the transition section is both less than the smallest radial stiffness of the radial stiffness of the support section and the radial stiffness of the leaflet section.
  • the open structure unit includes a first link and a second link, and one end of the first link is connected with one end of the second link to form a transition section connecting node, The other end of the first link is connected to the leaflet segment, and the other end of the second link is connected to the support segment.
  • the support section includes a plurality of support rods, the support rods are interconnected to form support section connection points, and the number of transition section connection nodes is less than the number of support section connection points.
  • the open structural unit includes a third link, a plurality of the third links are arranged at intervals along the circumferential direction of the transition section, and one end of the third link is connected to the The leaflet segments are connected, and the other end of the third link is connected with the support segment.
  • the projection of the third link on a plane passing through the central axis of the valve support intersects and forms an included angle with the central axis of the valve support.
  • the projection of the third link on a plane passing through the central axis of the valve holder is parallel to or coincident with the central axis of the valve holder.
  • the projection of the third link on a plane tangent to the surface of the transition section is any one of a straight line, an arc, or a broken line, or a straight line, an arc A combination of at least two of line or polyline.
  • the transition section and the support section are connected in a detachable manner, and/or the transition section and the leaflet section are connected in a detachable manner.
  • Another aspect of the present invention also provides an artificial heart valve, the artificial heart valve has the valve support described in any one of the above, further comprising:
  • a choke film, the choke film is provided on the valve leaflet segment and the transition segment;
  • valve leaflet includes a fixed edge and a free edge, the fixed edge is fixedly connected to the valve leaflet segment, and the free edge is opened and closed at an angle.
  • FIG. 1 is a schematic structural diagram of an artificial heart valve according to an embodiment of the present invention.
  • Fig. 2 is the structural representation of the valve stent in Fig. 1;
  • Fig. 3 is the structural representation of the valve leaflet segment in Fig. 1;
  • FIG. 4 is a schematic structural diagram of a tile-shaped structural unit in an expanded state in FIG. 3;
  • FIG. 5 is a schematic structural diagram of the tile-shaped structural unit in a contracted state in FIG. 3;
  • Fig. 6 is the structural representation of the support section in Fig. 1;
  • Fig. 7 is the structural representation of transition section in Fig. 1;
  • Fig. 8 is the structural representation of the valve leaflet in Fig. 1;
  • FIG. 9 is a partial structural schematic diagram of a valve stent according to another embodiment of the present invention.
  • FIG. 10 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention.
  • FIG. 11 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention.
  • FIG. 12 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention.
  • FIG. 13 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention.
  • FIG. 14 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention.
  • FIG. 15 is a partial structural schematic diagram of a valve stent according to another embodiment of the present invention.
  • Fig. 16 is a partial structural schematic diagram of the third connecting rod in Fig. 15;
  • FIG. 17 is an enlarged schematic view of the structure of part A in FIG. 16 .
  • valve stent 100: valve stent
  • 200 leaflet
  • 210 fixed edge
  • 220 free edge
  • 230 valve angle
  • A the first end point
  • B the connection point of the support section
  • C the connection point of the transition section.
  • first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be restricted by these terms. These terms may only be used to distinguish one element, component, region, layer or section from another region, layer or section. Terms such as “first,” “second,” and other numerical terms when used herein do not imply a sequence or order unless clearly indicated by the context. Thus, a first element, component, region, layer or section discussed below could be termed a second element, component, region, layer or section without departing from the teachings of example embodiments.
  • spatially relative terms may be used herein to describe the relationship of one element or feature to another element or feature as shown in the figures, such as “inner”, “outer”, “inner” “, “outside”, “below”, “below”, “above”, “above”, etc.
  • This spatially relative term is intended to include different orientations of the device in use or operation other than the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as “below” or “beneath” other elements or features would then be oriented “above” or “above the other elements or features" above features". Thus, the example term “below” can encompass both an orientation of above and below.
  • the device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly.
  • proximal and distal refers to the end closest to the operator, “distal” refers to the end away from the operator, and the phrase “axial”
  • proximal refers to the end closest to the operator
  • distal refers to the end away from the operator
  • axial refers to the direction in which the device is advanced and pushed out
  • circumferential direction refers to the direction around the axial direction in the present invention.
  • open structure unit refers to a unit that forms an unclosed structure on the transition section.
  • the present invention proposes an artificial heart valve 1000 .
  • the artificial heart valve 100 in this embodiment includes a valve stent 100 , a plurality of valve leaflets 200 and a flow blocking membrane 300 .
  • the flow blocking membrane 300 covers part of the structure of the valve support 100 , and the function of the blocking membrane 300 is mainly to fix the valve leaflets 200 and prevent blood from passing through areas other than the channels formed between the valve leaflets 200 .
  • the material of the blocking film 300 is preferably a polymer material, such as PET (polyterephthalic acid), PTFE (polytetrafluoroethylene), PU (polyurethane), etc., and biological tissue materials and tissue engineering materials can also be used. Material.
  • the leaflet 200 mainly functions as a one-way valve, allowing blood to flow from one end to the other end of the artificial heart valve and preventing blood from flowing back from the other end to the other end.
  • the valve leaflet 200 is preferably made of biological tissue materials, such as porcine pericardium, bovine pericardium, horse pericardium, sheep pericardium, pig heart valve, etc., and polymer materials and tissue engineering materials can also be used.
  • the valve stent 100 of the present embodiment has a tubular structure that can be switched between a contracted state and an expanded state, and FIG. 2 shows the expanded state of the valve stent 100 .
  • the valve support 100 includes a support segment 10 , a transition segment 30 and a valve leaflet segment 20 which are arranged in sequence.
  • the support segment 10 is a tubular structure in an expanded state, and is used for interference fit with the target position of human tissue after implantation and to generate radial support force, and to fix the artificial heart valve 1000 .
  • the leaflet segments 20 are used to secure the leaflets 200 .
  • the transition segment 30 is used to receive the valve leaflet segment 20 and the support segment 10, so that the support segment 10 and the valve leaflet segment 20 connected at both ends of the transition segment 30 can be unaffected by each other, thereby facilitating the blocking of the support segment 10 to the valve leaflet segment 20. Radial force transmission.
  • the maximum diameter of the leaflet segment 20 in this embodiment is smaller than the maximum diameter of the support segment 10 , preferably 10% to 20% smaller.
  • the blocking film 300 includes a first blocking film 301 and a second blocking film 302, the first blocking film 301 and the second blocking film 302 are spliced together, wherein the first blocking film 301 is disposed on the In the leaflet segment 20 , the second flow blocking membrane 302 is disposed on the transition segment 30 .
  • the maximum diameter dimension of the valve leaflet segment 20 is smaller than the maximum diameter dimension of the transition segment 30. Therefore, even if the valve leaflet segment 20 does not completely fit the target position, as long as the transition segment 30 can be fully fitted to the target position, it is arranged at the first position of the transition segment 30.
  • the second flow blocking membrane 302 can effectively prevent the penetration of blood.
  • the blocking membrane 300 of this embodiment is fixedly connected to the valve stent 100 by sutures, for example, is disposed on the inner surface or the outer surface of the valve stent 100 , and the blocking membrane 300 covers the valve leaflet section 20 and the transition section 30 of the valve stent 100 .
  • the function of the baffle film is mainly to fix the valve leaflet 200 and prevent the blood from flowing from the area outside the channel formed by the free edge 220 of the valve leaflet 200 .
  • the first blocking membrane 301 of the valve leaflet segment 20 can be made of a cylindrical cloth with the same size as the inner surface shape of the expanded valve stent 100, and the first blocking membrane 301 is not connected to the second blocking membrane 302.
  • the contour of one end can be trimmed according to the shape of the edge of the fixed side of the valve support 100 or the valve leaflet 200, or a flat mouth can be used directly.
  • the second flow blocking membrane 302 of the transition section 30 can be directly sewed with a tubular cloth of the same size as the expanded transition section 30 structure, or can be formed by splicing and stitching several fan-shaped small pieces.
  • the second flow blocking membrane 302 of the transition section 30 It can more effectively prevent peripheral leakage.
  • the suturing of the blocking membrane 300 is performed in the natural state of the expanded valve stent 100 , and the surface of the blocking membrane 300 is kept compact without affecting the shape of the valve stent 100 .
  • the materials of the first flow blocking membrane 301 of the leaflet segment 20 and the second flow blocking membrane 302 of the transition section 30 may be different or the same.
  • the material of the suture is preferably a polymer material, such as PET, PTFE, PU and the like.
  • the valve leaflet segment 20 is a tubular structure composed of a plurality of tile-shaped structural units 21 .
  • any axially collinear portion of the tile-shaped structural unit 21 The axial length between the two points remains the same.
  • valve leaflet segment 20 By designing the valve leaflet segment 20 as a tubular structure composed of a plurality of tile-like structural units 21, and in the process of switching between the contracted state and the expanded state of the valve stent 100, any axially collinear on the tile-like structural units 21 The axial length between the two points remains unchanged, which is beneficial to prevent the valve leaflet 200 and the blocking membrane 300 fixed on the valve leaflet segment 20 from being subjected to axial tension due to the axial deformation of the valve stent 100 during the process of sheathing and shrinking. , thereby effectively preventing the valve stent 100 from leaking due to tearing of the flow blocking membrane and the valve leaflets 200 .
  • the plurality of tile-shaped structural units 21 of the valve leaflet segment 20 are sequentially arranged along the circumferential direction and the axial direction of the valve leaflet segment 20 .
  • the tile-shaped structural unit 21 includes two V-shaped connecting rods 211 and two straight rods 212 .
  • the two V-shaped links 211 are arranged at intervals along the axial direction of the leaflet segment 20 , and the opening directions of the two V-shaped links 211 are the same.
  • the two straight rods 212 are arranged at intervals along the circumferential direction of the leaflet segment 20 , and the two V-shaped links 211 are connected by the two straight rods 212 .
  • the V-shaped connecting rod 211 is formed by connecting two sections of curved rods, and the first end point A is formed at the connection of the two sections of curved rods. Both ends of each V-shaped link 211 are fixed on adjacent straight rods 212 evenly distributed in the circumferential direction.
  • the valve 200 is effectively supported, and in the process of the valve leaflet segment 20 being squeezed and deformed, the deformation of each position in the circumferential direction is kept consistent.
  • the circumferentially distributed V-shaped connecting rods 211 adopt an equidistant array, the number of arrays is greater than or equal to 2, and the spacing of the arrays is greater than the distance between the two ends of the curved rod, that is, the length of the straight rod 212 is greater than that of the V-shaped connecting rod 211.
  • the maximum length in the axial direction of the leaflet segment 20 is preferably 3 rows, so as to ensure that the V-shaped link 211 has sufficient deformation space in the axial direction during the process of the leaflet segment 20 being squeezed and deformed.
  • the two V-shaped connecting rods 211 disposed adjacent to each other in the axial direction are prevented from being pressed against each other, thereby causing tearing of the flow blocking membrane and the valve leaflets 200 , thereby causing leakage of the valve stent 100 .
  • the straight rod 212 is not deformed during the switching process, and still retains the vertical state in the axial direction.
  • the V-shaped link 211 is deformed. Since the structures of the two V-shaped links 211 are the same, the synchronous deformation is always maintained during the state switching process of the tile-shaped structural unit 21, and the axial distance between the two V-shaped links 211 is always maintained. In order to ensure that the distance between any axially collinear two points in the tile-shaped structural unit 21 will remain unchanged when the valve stent 100 is switched between the expanded state and the contracted state.
  • the leaflet segment 20 further includes a leaflet frame 40 .
  • the leaflet frame 40 is disposed at the end of the leaflet segment 20 that is not connected to the transition segment 30. Specifically, the leaflet frame 40 is arranged on the straight rod 212 at equal intervals. In this embodiment, the leaflet frame 40 is provided with The leaflet frame is used to fix the valve angle of the leaflet 200 on the straight rods 212 that are equally spaced as the number of leaflets 200 .
  • the inside of the leaflet frame 40 is provided with a rectangular hollow structure for fixing the valve angle of the leaflet 200 .
  • the valve stent 100 of the present embodiment further includes a connecting portion 50 .
  • the connecting portion 50 is connected to the end of the leaflet frame 40 , and the leaflet frame 40 is disposed between the connecting portion 50 and the straight rod 212 .
  • the connecting portion 50 is a T-shaped structure, and the connecting portion 50 is used to connect the valve stent 100 and the delivery device during the delivery process.
  • the support section 10 of the present embodiment has a tubular structure as a whole in an expanded state, and includes a plurality of support rods 11 , and the plurality of support rods 11 are connected through the support section connection point B to form a circumferential closed shape .
  • the head and tail of each support rod 11 are connected through the support section connection point B to form a diamond-shaped structural unit.
  • the diamond-shaped structural units are distributed in a uniform array around the axis of the support section 10 , and the number of arrays is preferably an integer multiple of the number of straight rods 212 of the leaflet section 20 .
  • the second, third and even more layers in the axial direction are then designed through the honeycomb structure.
  • the support section 10 has two layers of diamond-shaped structural units.
  • the use of diamond-shaped structural units for the support section 10 can ensure that sufficient radial support force can still be provided when compressed to a smaller diameter.
  • the transition section 30 in the expanded state, has a tubular structure with a large proximal end and a small distal end as a whole.
  • the transition section 30 includes a plurality of first connecting rods 31 and a plurality of second connecting rods 32.
  • One end of the first connecting rod 31 is connected with one end of the second connecting rod 32 to form a connecting node C of the transition section.
  • the other end is connected to the leaflet segment 20 , and the other end of the second link 32 is connected to the support segment 10 .
  • the two first links 31 and the two second links 32 form an "X"-shaped open structure unit 303
  • the length of the first links 31 is greater than the length of the second links 32
  • the second The length of the connecting rod 32 is approximately equal to the length of the support rod 11, so that the distance between any two adjacent first connecting rods 31 in the circumferential direction is greater than any two adjacent second connecting rods 32 in the circumferential direction. The distance between them ensures that the transition section 30 has better compressibility.
  • the number of transition section connection nodes C is less than the number of support section connection points B in the same circumferential direction on the support section 10
  • the number of support section connection points B is an integer multiple of the number of transition section connection nodes C. The reduction in the number of end points in the circumferential direction of the transition section 30 can reduce the radial stiffness of the valve stent 100 , and can effectively prevent the support section 10 from transmitting radial force to the valve leaflet section 20 .
  • the proximal end of the valve leaflet segment 20 in this embodiment is further provided with a connecting rod 22 arranged in the axial direction, and the connecting rod 22 is provided on two adjacent tile-shaped structural units. 21, one end of the first connecting rod 31 is connected to the proximal end of the valve leaflet segment 20 through the connecting rod 22, the other end of the first connecting rod 31 is connected to one end of the second connecting rod 32 through the transition section connecting node C, The other end of the second link 32 is connected to the distal end of the support section 10 through the support section connecting point B.
  • the transition section 30 is provided with an open structural unit 303, so that it does not form a closed structure unit, so that the transition section 30 has a weaker radial rigidity, so that the support section 10 and the leaflet section 20 connected at both ends of the transition section 30 can not be affected by each other. Therefore, it is beneficial to block the radial force transmission from the support segment 10 to the valve leaflet segment 20, so that during the release process, the valve leaflet segment 20 or the support segment 10 can be completely released first, while the other segment is retained in the delivery sheath, which is beneficial to Choose the most suitable state to release during use to reduce the difficulty of operation.
  • the valve stent 100 is made of an alloy tube by laser cutting, and the material is preferably superelastic nickel-titanium alloy and stainless steel, and is subsequently expanded, shaped and surface treated by heat treatment to achieve the required design shape, size and surface quality.
  • valve leaflet segment 20 and the support segment 10 By arranging the valve leaflet segment 20 and the support segment 10 separately on the valve support 100, and providing a buffering transition segment 30 between the valve leaflet segment 20 and the support segment 10, the shrinkage of the valve support 100 can be effectively reduced
  • the radial force transmitted by the support segment 10 to the valve leaflet segment 30 during the deformation process can achieve the ideal working state of retaining the circular cross-section of the valve leaflet 200 to a greater extent.
  • the transition section 30 of the valve stent 100 adopts a structure with lower rigidity (open structural unit).
  • the valve leaflet section 20 or the support section 10 can be completely released first, while the other section is retained in the delivery sheath. It is beneficial to select the most suitable state for release during use, reducing the difficulty of operation.
  • the artificial heart valve 1000 of this embodiment is provided with three leaflets 200 in total.
  • the structure and shape of the leaflets 200 are the same. internal.
  • the valve leaflet 200 includes a fixed edge 210 and a free edge 220, wherein the fixed edge 210 is fixed on the blocking membrane of the valve leaflet segment 20 by sutures, and the free edge 220 is not constrained and can be opened and closed at an angle.
  • the valve angle 230 passes through the leaflet frame 40 of the leaflet segment 20 from the inside to the outside, and then goes around the rod on the leaflet frame 40 and folds back outward to fit the valve leaflet 200 in the valve support 100, and use sutures to be fixed.
  • the structure of the transition section 30 of the valve stent 100 is different from the above-mentioned embodiments.
  • the transition section 30 is composed of a plurality of third connecting rods 33 spaced in the circumferential direction, and the third connecting rods 33 may be simple straight rods.
  • the distal end of the third link 33 is connected to the first end point A of the proximal end of the valve leaflet segment 20 , and the proximal end of the third link 33 is connected to the support segment connection point B at the distal end of the support segment 10 .
  • the projection of the third link 33 on the plane of the central axis O of the valve stent is parallel to or coincident with the central axis O of the valve stent.
  • the open structural unit includes the third connecting rod 33 , and the arrangement of the third connecting rod 33 on the transition section 30 forms an open structural unit on the transition section 30 .
  • the structure of the third link 33 may also be modified.
  • the projection of the third link 33 on the plane tangent to the surface of the transition section 30 is any one of a straight line, an arc shape or a broken line shape, or a combination of at least two of the straight line, arc shape or broken line shape .
  • the projection of the third link 33 on a plane tangent to the surface of the transition section 30 may be an arc segment, a multi-rod segment with an angle, a curved segment with a wave circle, a belt Either a bent bar segment with multiple S-bends or a multi-bar segment with a dash shape.
  • an elastic member can be added to the third connecting rod 33 in the axial direction, which reduces the rigidity of the third connecting rod 33 itself, thereby reducing the transition section.
  • the radial stiffness of 30 is favorable for blocking the transmission of radial force from the support segment 10 to the leaflet segment 20 .
  • the projection of the third link 33 on the plane of the central axis O of the transvalvular stent intersects and forms an included angle with the central axis O of the valve stent, that is, the The third link 33 is inclined in the axial direction.
  • the valve stent 100 can be twisted to relieve the pressure when it is under force, thereby reducing the radial stiffness of the transition section 30, thereby facilitating the blocking of the support section 10 from the valve leaflet. Segment 20 transmits radial forces.
  • the transition segment 30 and the valve leaflet segment 20 and/or the support segment 10 adopt a split structure design, that is, the transition segment 30 is detachably connected to the valve leaflet segment 20 and/or the support segment 10 in a detachable manner. connected.
  • one end of the leaflet segment 20 , both ends of the third link 33 and one end of the support segment 10 are provided with mounting holes, and one end of the third link 33 passes through a retaining ring 60 is connected to one end of the leaflet segment 20 through the mounting hole, and the other end of the third link 33 is connected to one end of the support segment 10 through the retaining ring 60 through the mounting hole, so that the two ends of the third link 33 are respectively connected to the one end of the support segment 10.
  • the first end point A is independent of the connection point B of the support segment, so as to avoid the transmission of torque generated by the support segment 10 at the connection point B of the support segment, thereby reducing the influence on the deformation of the leaflet segment 20 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

A valve stent (100) having a tubular structure and comprising a support section (10), a transition section (30), and a lobe section (20), the transition section (30) being used for connecting the support section (10) and the lobe section (20), the maximum diameter of the lobe section (20) being less than the maximum diameter of the transition section (30), and the maximum diameter of the transition section (30) being less than or equal to the maximum diameter of the support section (10), the transition section (30) comprising a plurality of first connecting rods (31) and a plurality of second connecting rods (32), and the first connecting rods (31) and the second connecting rods (32) forming at least one open structural unit (303) on the transition section (30), thereby facilitating prevention of the problem of incomplete closure and excessive central reflux easily occurring when the valve stent (100) is implanted in the target position due to the opening and closing effect of the lobe (200) being affected by the form of the target position.

Description

瓣膜支架及人工心脏瓣膜Valve stents and artificial heart valves 技术领域technical field
本发明属于医疗器械技术领域,具体涉及一种瓣膜支架及人工心脏瓣膜。The invention belongs to the technical field of medical devices, and in particular relates to a valve support and an artificial heart valve.
背景技术Background technique
人的心脏主要作用是给人体内的血液提供动力。心脏在解剖学角度上可分为:右心房、右心室、左心房和左心室。血液从上腔静脉和下腔静脉流入右心房,然后经过三尖瓣流入右心室,在右心室收缩的作用下血液通过肺动脉瓣膜流入肺部。血液在肺部交换得到氧气后流入左心房内,然后经过二尖瓣流入左心室,在左心室的收缩作用下血液经过主动脉瓣膜流入人体的各个部位。人体心脏内总共带有四个瓣膜,分别是三尖瓣、肺动脉瓣膜、二尖瓣和主动脉瓣膜。三尖瓣位于右心房和右心室之间;二尖瓣位于左心房和左心室之间。天然形成的正常瓣膜一般带有两或三片瓣叶,瓣叶的根部固定在瓣环上;瓣叶的自由边无其它结构或连接有腱索,腱索的另一端连接心肌壁上的乳头肌上。瓣膜的作用都是起到限制血流的方向,瓣叶打开时允许血液从瓣膜的流入端向流出端流动,瓣叶闭合时阻止血液从瓣膜的流出端向流入端流动。四个瓣膜都位于心室的出入口上,当心室舒张时,三尖瓣和二尖瓣打开,肺动脉瓣膜和主动脉瓣膜关闭,血液从心房流入心室中;当心室收缩时,三尖瓣和二尖瓣关闭,肺动脉瓣膜和主动脉瓣膜打开,血液从心室流入动脉内。由此可见,瓣膜的开闭功能是否正常将直接影响人体的心脏功能能否正常地为血液提供动力。The main function of the human heart is to provide power for the blood in the human body. The heart is anatomically divided into: right atrium, right ventricle, left atrium, and left ventricle. Blood flows from the superior vena cava and inferior vena cava into the right atrium, then through the tricuspid valve into the right ventricle, where blood flows through the pulmonary valve into the lungs under the action of right ventricular contraction. The blood flows into the left atrium after being exchanged for oxygen in the lungs, and then flows into the left ventricle through the mitral valve. There are four valves in the human heart, namely the tricuspid valve, the pulmonary valve, the mitral valve and the aortic valve. The tricuspid valve is located between the right atrium and the right ventricle; the mitral valve is located between the left atrium and the left ventricle. Naturally formed normal valves generally have two or three leaflets, and the roots of the leaflets are fixed on the valve annulus; the free edges of the leaflets have no other structures or are connected with chordae tendineae, and the other end of the chordae tendineae is connected to the papilla on the myocardial wall. on the muscle. The function of the valve is to restrict the direction of blood flow. When the valve leaflet is open, it allows blood to flow from the inflow end to the outflow end of the valve, and when the valve leaflet is closed, it prevents blood from flowing from the outflow end to the inflow end of the valve. All four valves are located at the entrance and exit of the ventricle. When the ventricle dilates, the tricuspid and mitral valves open, the pulmonary and aortic valves close, and blood flows from the atrium into the ventricle; when the ventricle contracts, the tricuspid and mitral valves The valves close, the pulmonary and aortic valves open, and blood flows from the ventricles into the arteries. It can be seen that whether the opening and closing function of the valve is normal will directly affect whether the heart function of the human body can provide power for the blood normally.
目前心脏瓣膜病变已经成为常见的心血管疾病之一,其病理改变主要以瓣膜关闭不全为主,根据病因可分为两类:第一类为器质性,是由于瓣膜的瓣叶本身器质性病变发生,病因主要有瓣膜先天性畸形或者缺损、风湿性瓣膜病、钙化等;第二类为功能性,瓣膜本身没有器质性病变,主要由于心房扩大、高压等间接原因引起瓣环、乳头肌、腱索、心肌壁等在空间上的异常。近几年来,随着介入器械的不断完善以及相关经验的积累,介入心脏瓣膜支架开始应用于主动脉瓣、肺动脉瓣、二尖瓣、三尖瓣等不宜进行外科手术的病例,完成的病例数正快速增长,多个临床试验也正在加紧进行中,试验的结果将会为该技术 的应用提供更多的循证医学证据。At present, heart valve disease has become one of the common cardiovascular diseases, and its pathological changes are mainly valvular insufficiency. According to the cause, it can be divided into two categories: the first type is organic, which is due to the organic nature of the valve leaflets themselves. The main causes are congenital malformation or defect of the valve, rheumatic valve disease, calcification, etc.; the second category is functional, the valve itself has no organic disease, mainly due to indirect causes such as atrial enlargement and high pressure. Spatial abnormalities of papillary muscles, chordae tendineae, myocardial wall, etc. In recent years, with the continuous improvement of interventional devices and the accumulation of relevant experience, interventional heart valve stents have begun to be used in aortic valve, pulmonary valve, mitral valve, tricuspid valve and other cases that are not suitable for surgical operations. It is growing rapidly, and multiple clinical trials are also underway. The results of the trials will provide more evidence-based medical evidence for the application of this technology.
然而,现有临床使用和设计阶段的介入人工心脏瓣膜设计存在一些问题与缺陷。例如,现有瓣膜中瓣叶固定于瓣膜支架的支撑段,在植入后瓣膜功能受瓣膜支架的支撑段形态影响,若植入部位横截面偏椭圆状,瓣叶的工作实况与设计时瓣膜支架横截面的圆形状态存在较大差异,瓣叶的打开和闭合效果受影响,容易出现关闭不全和中心反流过多的现象。However, there are some problems and deficiencies in the current interventional prosthetic heart valve design in clinical use and design stage. For example, in the existing valve, the leaflet is fixed to the support section of the valve stent, and the valve function after implantation is affected by the shape of the support section of the valve stent. There is a big difference in the circular state of the cross section of the stent, the opening and closing effects of the valve leaflets are affected, and the phenomenon of regurgitation and excessive central regurgitation are prone to occur.
发明内容SUMMARY OF THE INVENTION
本发明的目的是至少解决支架在植入目标位置时,瓣叶的打开和闭合效果受目标位置形态的影响容易出现关闭不全和中心反流过多的问题。The purpose of the present invention is to at least solve the problem of insufficiency and excessive central regurgitation caused by the influence of the shape of the target position on the opening and closing effect of the valve leaflet when the stent is implanted at the target position.
本发明的第一方面提出了一种瓣膜支架,所述瓣膜支架呈管状结构,所述瓣膜支架包括支撑段、过渡段和瓣叶段,所述过渡段用于连接所述支撑段和所述瓣叶段,所述瓣叶段用于设置瓣叶,所述支撑段用于支撑所述瓣膜支架,所述瓣叶段的最大直径尺寸小于所述过渡段的最大直径,所述过渡段的最大直径小于或等于所述支撑段的最大直径尺寸,其中,所述过渡段包括若干连杆,所述连杆在所述过渡段上形成至少一开放结构单元。A first aspect of the present invention provides a valve support, the valve support has a tubular structure, the valve support includes a support section, a transition section and a valve leaflet section, and the transition section is used to connect the support section and the valve support section. The valve leaflet segment, the valve leaflet segment is used for setting the valve leaflet, the support segment is used for supporting the valve support, the maximum diameter of the valve leaflet segment is smaller than the maximum diameter of the transition segment, and the transition segment has a maximum diameter. The maximum diameter is smaller than or equal to the maximum diameter of the support section, wherein the transition section includes several connecting rods, and the connecting rods form at least one open structural unit on the transition section.
根据发明中的瓣膜支架,通过设置支撑段、过渡段和瓣叶段,瓣叶段设置有瓣叶,支撑段用于支撑整个瓣膜支架,过渡段的最大直径小于或等于支撑段的最大直径尺寸,使支撑段能支撑在目标位置而进行贴合,瓣叶段的最大直径尺寸小于过渡段的最大直径,使过渡段贴合目标位置时,设置有瓣叶的瓣叶段不需要完全贴合目标位置,因此设置有瓣叶的瓣叶段不容易受到目标位置形态的影响,而出现关闭不全和中心反流过多的问题。并且,过渡段用于连接支撑段和瓣叶段,过渡段包括若干连杆,连杆在过渡段上形成开放结构单元,使过渡段的径向刚度降低,使连接在过渡段两端的支撑段和瓣叶段能够相互不受影响,从而有利于阻隔支撑段向瓣叶段的径向力传递,使得在释放过程中,可以先完全释放瓣叶段或支撑段,而保留另一段在输送鞘内,有利于在使用过程中选择最合适状态进行释放,降低操作难度。According to the valve stent in the invention, by providing a support segment, a transition segment and a valve leaflet segment, the valve leaflet segment is provided with valve leaflets, the support segment is used to support the entire valve stent, and the maximum diameter of the transition segment is smaller than or equal to the maximum diameter of the support segment. , so that the support segment can be supported at the target position for fitting, and the maximum diameter of the valve leaflet segment is smaller than the maximum diameter of the transition segment. When the transition segment fits the target position, the valve leaflet segment provided with the valve leaflet does not need to be completely fitted The target position, so the leaflet segment provided with the leaflet is not easily affected by the shape of the target position, and the problems of insufficiency and excessive central regurgitation occur. In addition, the transition section is used to connect the support section and the leaflet section, and the transition section includes several connecting rods. The connecting rods form an open structural unit on the transition section, so that the radial stiffness of the transition section is reduced, so that the support sections connected at both ends of the transition section are connected. and the valve leaflet segment can be unaffected by each other, which is beneficial to block the radial force transmission from the support segment to the valve leaflet segment, so that during the release process, the valve leaflet segment or the support segment can be completely released first, while the other segment is retained in the delivery sheath. It is beneficial to select the most suitable state for release during use, reducing the difficulty of operation.
另外,根据本发明的瓣膜支架,还可具有如下附加的技术特征:In addition, the valve stent according to the present invention may also have the following additional technical features:
在本发明的一些实施方式中,所述过渡段的径向刚度均小于所述支撑段的 径向刚度和所述瓣叶段的径向刚度中最小的径向刚度。In some embodiments of the present invention, the radial stiffness of the transition section is both less than the smallest radial stiffness of the radial stiffness of the support section and the radial stiffness of the leaflet section.
在本发明的一些实施方式中,所述开放结构单元包括第一连杆和第二连杆,所述第一连杆的一端与所述第二连杆的一端连接,形成过渡段连接节点,所述第一连杆的另一端与所述瓣叶段相连,所述第二连杆的另一端与所述支撑段相连。In some embodiments of the present invention, the open structure unit includes a first link and a second link, and one end of the first link is connected with one end of the second link to form a transition section connecting node, The other end of the first link is connected to the leaflet segment, and the other end of the second link is connected to the support segment.
在本发明的一些实施方式中,所述支撑段包括若干支撑杆,所述支撑杆相互连接,形成支撑段连接点,所述过渡段连接节点的数量少于所述支撑段连接点的数量。In some embodiments of the present invention, the support section includes a plurality of support rods, the support rods are interconnected to form support section connection points, and the number of transition section connection nodes is less than the number of support section connection points.
在本发明的一些实施方式中,所述开放结构单元包括第三连杆,多个所述第三连杆沿所述过渡段的周向方向间隔设置,所述第三连杆的一端与所述瓣叶段相连,所述第三连杆的另一端与所述支撑段相连。In some embodiments of the present invention, the open structural unit includes a third link, a plurality of the third links are arranged at intervals along the circumferential direction of the transition section, and one end of the third link is connected to the The leaflet segments are connected, and the other end of the third link is connected with the support segment.
在本发明的一些实施方式中,所述第三连杆在经所述瓣膜支架的中心轴线的平面上的投影与所述瓣膜支架的中心轴线相交并形成夹角。In some embodiments of the present invention, the projection of the third link on a plane passing through the central axis of the valve support intersects and forms an included angle with the central axis of the valve support.
在本发明的一些实施方式中,所述第三连杆在经所述瓣膜支架的中心轴线的平面上的投影与所述瓣膜支架的中心轴线平行或者重合。In some embodiments of the present invention, the projection of the third link on a plane passing through the central axis of the valve holder is parallel to or coincident with the central axis of the valve holder.
在本发明的一些实施方式中,所述第三连杆在与所述过渡段表面相切的平面的投影为直线形、弧线形或折线形中的任一种,或者为直线形、弧线形或折线形中至少两种的组合。In some embodiments of the present invention, the projection of the third link on a plane tangent to the surface of the transition section is any one of a straight line, an arc, or a broken line, or a straight line, an arc A combination of at least two of line or polyline.
在本发明的一些实施方式中,所述过渡段与所述支撑段间以可拆卸的方式相连,和/或所述过渡段与所述瓣叶段之间以可拆卸的方式相连。In some embodiments of the present invention, the transition section and the support section are connected in a detachable manner, and/or the transition section and the leaflet section are connected in a detachable manner.
本发明的另一方面还提出了一种人工心脏瓣膜,所述人工心脏瓣膜具有上述任一项所述的瓣膜支架,还包括:Another aspect of the present invention also provides an artificial heart valve, the artificial heart valve has the valve support described in any one of the above, further comprising:
阻流膜,所述阻流膜设于所述瓣叶段和所述过渡段;A choke film, the choke film is provided on the valve leaflet segment and the transition segment;
多个瓣叶,所述瓣叶包括固定边和自由边,所述固定边固定连接于所述瓣叶段,所述自由边呈角度的开合。A plurality of valve leaflets, the valve leaflet includes a fixed edge and a free edge, the fixed edge is fixedly connected to the valve leaflet segment, and the free edge is opened and closed at an angle.
附图说明Description of drawings
通过阅读下文优选实施方式的详细描述,各种其它的优点和益处对于本领域普通技术人员将变得清楚明了。附图仅用于示出优选实施方式的目的,而并 不认为是对本发明的限制。而且在整个附图中,用相同的附图标记表示相同的部件。其中:Various other advantages and benefits will become apparent to those of ordinary skill in the art upon reading the following detailed description of the preferred embodiments. The drawings are for the purpose of illustrating preferred embodiments only and are not to be considered limiting of the invention. Also, the same components are denoted by the same reference numerals throughout the drawings. in:
图1为本发明实施方式的人工心脏瓣膜的结构示意图;1 is a schematic structural diagram of an artificial heart valve according to an embodiment of the present invention;
图2为图1中瓣膜支架的结构示意图;Fig. 2 is the structural representation of the valve stent in Fig. 1;
图3为图1中瓣叶段的结构示意图;Fig. 3 is the structural representation of the valve leaflet segment in Fig. 1;
图4为图3中瓦片状结构单元扩张状态下的结构示意图;4 is a schematic structural diagram of a tile-shaped structural unit in an expanded state in FIG. 3;
图5为图3中瓦片状结构单元收缩状态下的结构示意图;FIG. 5 is a schematic structural diagram of the tile-shaped structural unit in a contracted state in FIG. 3;
图6为图1中支撑段的结构示意图;Fig. 6 is the structural representation of the support section in Fig. 1;
图7为图1中过渡段的结构示意图;Fig. 7 is the structural representation of transition section in Fig. 1;
图8为图1中瓣叶的结构示意图;Fig. 8 is the structural representation of the valve leaflet in Fig. 1;
图9为本发明另一实施方式的瓣膜支架的部分结构示意图;FIG. 9 is a partial structural schematic diagram of a valve stent according to another embodiment of the present invention;
图10为本发明另一实施方式的第三连杆的部分结构示意图;10 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention;
图11为本发明另一实施方式的第三连杆的部分结构示意图;11 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention;
图12为本发明另一实施方式的第三连杆的部分结构示意图;12 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention;
图13为本发明另一实施方式的第三连杆的部分结构示意图;13 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention;
图14为本发明另一实施方式的第三连杆的部分结构示意图;14 is a partial structural schematic diagram of a third connecting rod according to another embodiment of the present invention;
图15为本发明另一实施方式的瓣膜支架的部分结构示意图;FIG. 15 is a partial structural schematic diagram of a valve stent according to another embodiment of the present invention;
图16为图15中第三连杆的部分结构示意图;Fig. 16 is a partial structural schematic diagram of the third connecting rod in Fig. 15;
图17为图16中A部的放大结构示意图。FIG. 17 is an enlarged schematic view of the structure of part A in FIG. 16 .
附图中各标号表示如下:The reference numbers in the accompanying drawings are as follows:
1000:人工心脏瓣膜;1000: artificial heart valve;
100:瓣膜支架;100: valve stent;
O:瓣膜支架的中心轴线O: the central axis of the valve stent
10:支撑段、11:支撑杆;10: support section, 11: support rod;
20:瓣叶段、21:瓦片状结构单元、211:V型连杆、212:直杆、22:连接杆;20: leaflet segment, 21: tile-like structural unit, 211: V-shaped link, 212: straight rod, 22: connecting rod;
30:过渡段、31:第一连杆、32:第二连杆、33:第三连杆;30: transition section, 31: first link, 32: second link, 33: third link;
40:瓣叶框;40: leaflet frame;
50:连接部;50: connecting part;
60:扣环;60: buckle;
200:瓣叶、210:固定边、220:自由边、230:瓣角;200: leaflet, 210: fixed edge, 220: free edge, 230: valve angle;
A:第一端点、B:支撑段连接点、C:过渡段连接节点。A: the first end point, B: the connection point of the support section, C: the connection point of the transition section.
300:阻流膜、301:第一阻流膜、302:第二阻流膜300: blocking film, 301: first blocking film, 302: second blocking film
具体实施方式detailed description
下面将参照附图更详细地描述本发明的示例性实施方式。虽然附图中显示了本发明的示例性实施方式,然而应当理解,可以以各种形式实现本发明而不应被这里阐述的实施方式所限制。相反,提供这些实施方式是为了能够更透彻地理解本发明,并且能够将本发明的范围完整的传达给本领域的技术人员。Exemplary embodiments of the present invention will be described in more detail below with reference to the accompanying drawings. While exemplary embodiments of the present invention are shown in the drawings, it should be understood that the present invention may be embodied in various forms and should not be limited by the embodiments set forth herein. Rather, these embodiments are provided so that the present invention will be more thoroughly understood, and will fully convey the scope of the present invention to those skilled in the art.
应理解的是,文中使用的术语仅出于描述特定示例实施方式的目的,而无意于进行限制。除非上下文另外明确地指出,否则如文中使用的单数形式“一”、“一个”以及“所述”也可以表示包括复数形式。术语“包括”、“包含”、“含有”以及“具有”是包含性的,并且因此指明所陈述的特征、步骤、操作、元件和/或部件的存在,但并不排除存在或者添加一个或多个其它特征、步骤、操作、元件、部件、和/或它们的组合。文中描述的方法步骤、过程、以及操作不解释为必须要求它们以所描述或说明的特定顺序执行,除非明确指出执行顺序。还应当理解,可以使用另外或者替代的步骤。It is to be understood that the terminology used herein is for the purpose of describing particular example embodiments only and is not intended to be limiting. As used herein, the singular forms "a," "an," and "the" can also be intended to include the plural forms unless the context clearly dictates otherwise. The terms "comprising", "comprising", "containing" and "having" are inclusive and thus indicate the presence of stated features, steps, operations, elements and/or components, but do not preclude the presence or addition of one or Various other features, steps, operations, elements, components, and/or combinations thereof. Method steps, procedures, and operations described herein are not to be construed as requiring that they be performed in the particular order described or illustrated, unless an order of performance is explicitly indicated. It should also be understood that additional or alternative steps may be used.
尽管可以在文中使用术语第一、第二、第三等来描述多个元件、部件、区域、层和/或部段,但是,这些元件、部件、区域、层和/或部段不应被这些术语所限制。这些术语可以仅用来将一个元件、部件、区域、层或部段与另一区域、层或部段区分开。除非上下文明确地指出,否则诸如“第一”、“第二”之类的术语以及其它数字术语在文中使用时并不暗示顺序或者次序。因此,以下讨论的第一元件、部件、区域、层或部段在不脱离示例实施方式的教导的情况下可以被称作第二元件、部件、区域、层或部段。Although the terms first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be restricted by these terms. These terms may only be used to distinguish one element, component, region, layer or section from another region, layer or section. Terms such as "first," "second," and other numerical terms when used herein do not imply a sequence or order unless clearly indicated by the context. Thus, a first element, component, region, layer or section discussed below could be termed a second element, component, region, layer or section without departing from the teachings of example embodiments.
为了便于描述,可以在文中使用空间相对关系术语来描述如图中示出的一个元件或者特征相对于另一元件或者特征的关系,这些相对关系术语例如为“内部”、“外部”、“内侧”、“外侧”、“下面”、“下方”、“上面”、“上方”等。这种空间相对关系术语意于包括除图中描绘的方位之外的在使用或者操作中装置的 不同方位。例如,如果在图中的装置翻转,那么描述为“在其它元件或者特征下面”或者“在其它元件或者特征下方”的元件将随后定向为“在其它元件或者特征上面”或者“在其它元件或者特征上方”。因此,示例术语“在……下方”可以包括在上和在下的方位。装置可以另外定向(旋转90度或者在其它方向)并且文中使用的空间相对关系描述符相应地进行解释。For ease of description, spatially relative terms may be used herein to describe the relationship of one element or feature to another element or feature as shown in the figures, such as "inner", "outer", "inner" ", "outside", "below", "below", "above", "above", etc. This spatially relative term is intended to include different orientations of the device in use or operation other than the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as "below" or "beneath" other elements or features would then be oriented "above" or "above the other elements or features" above features". Thus, the example term "below" can encompass both an orientation of above and below. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly.
为了便于描述,以下描述使用术语“近端”和“远端”,其中“近端”是指的是离操作者近的一端,“远端”是指远离操作者的一端,短语“轴向方向”在本发明里表示本装置被推进和推出的方向,短语“周向方向”在本发明里表示围绕轴向方向的方向。For ease of description, the following description uses the terms "proximal" and "distal", where "proximal" refers to the end closest to the operator, "distal" refers to the end away from the operator, and the phrase "axial" In the present invention, "direction" refers to the direction in which the device is advanced and pushed out, and the phrase "circumferential direction" refers to the direction around the axial direction in the present invention.
在本实施例中,“开放结构单元”指在过渡段上形成不封闭结构的单元。In this embodiment, "open structure unit" refers to a unit that forms an unclosed structure on the transition section.
如图1所示,本发明提出了一种人工心脏瓣膜1000,本实施方式的人工心脏瓣膜100包括瓣膜支架100、多个瓣叶200和阻流膜300。其中,阻流膜300覆盖于瓣膜支架100的部分结构上,阻流膜300的作用主要起固定瓣叶200和阻止血液从瓣叶200间形成的通道以外的区域通过。阻流膜300的材料优先选用高分子材料,如PET(聚对苯二甲酸类)、PTFE(聚四氟乙烯)、PU(聚氨基甲酸酯)等,也可选用生物组织材料和组织工程材料。瓣叶200主要起单向阀功能,允许血液从人工心脏瓣膜的一端向另一端流动,而阻止血液从另一端向一端回流。瓣叶200优先选择生物组织材料,如猪心包、牛心包、马心包、羊心包、猪心瓣等,也可选用高分子材料和组织工程材料。As shown in FIG. 1 , the present invention proposes an artificial heart valve 1000 . The artificial heart valve 100 in this embodiment includes a valve stent 100 , a plurality of valve leaflets 200 and a flow blocking membrane 300 . Wherein, the flow blocking membrane 300 covers part of the structure of the valve support 100 , and the function of the blocking membrane 300 is mainly to fix the valve leaflets 200 and prevent blood from passing through areas other than the channels formed between the valve leaflets 200 . The material of the blocking film 300 is preferably a polymer material, such as PET (polyterephthalic acid), PTFE (polytetrafluoroethylene), PU (polyurethane), etc., and biological tissue materials and tissue engineering materials can also be used. Material. The leaflet 200 mainly functions as a one-way valve, allowing blood to flow from one end to the other end of the artificial heart valve and preventing blood from flowing back from the other end to the other end. The valve leaflet 200 is preferably made of biological tissue materials, such as porcine pericardium, bovine pericardium, horse pericardium, sheep pericardium, pig heart valve, etc., and polymer materials and tissue engineering materials can also be used.
本实施方式的瓣膜支架100为可在收缩状态和扩张状态间进行切换的管状结构,图2所示为瓣膜支架100的扩张状态。其中,瓣膜支架100包括依次设置的支撑段10、过渡段30和瓣叶段20。支撑段10在扩张状态下为管状结构,用于植入后与人体组织目标位置过盈配合并产生径向支撑力,起固定人工心脏瓣膜1000的作用。瓣叶段20用于固定瓣叶200。过渡段30用于承接瓣叶段20和支撑段10,使连接在过渡段30两端的支撑段10和瓣叶段20能够相互不受影响,从而有利于阻隔支撑段10向瓣叶段20的径向力传递。The valve stent 100 of the present embodiment has a tubular structure that can be switched between a contracted state and an expanded state, and FIG. 2 shows the expanded state of the valve stent 100 . Wherein, the valve support 100 includes a support segment 10 , a transition segment 30 and a valve leaflet segment 20 which are arranged in sequence. The support segment 10 is a tubular structure in an expanded state, and is used for interference fit with the target position of human tissue after implantation and to generate radial support force, and to fix the artificial heart valve 1000 . The leaflet segments 20 are used to secure the leaflets 200 . The transition segment 30 is used to receive the valve leaflet segment 20 and the support segment 10, so that the support segment 10 and the valve leaflet segment 20 connected at both ends of the transition segment 30 can be unaffected by each other, thereby facilitating the blocking of the support segment 10 to the valve leaflet segment 20. Radial force transmission.
本实施方式的瓣叶段20的最大直径尺寸小于支撑段10的最大直径尺寸,优选小10%~20%,支撑段10在目标位置中过盈配合产生支撑力后,瓣叶段20不需要完全贴合目标位置,因此设置有瓣叶200的瓣叶段20不容易受到目标位 置形态的影响,瓣叶段20能够保持原本的形状,从而避免出现关闭不全和中心反流过多的问题。The maximum diameter of the leaflet segment 20 in this embodiment is smaller than the maximum diameter of the support segment 10 , preferably 10% to 20% smaller. After the support segment 10 is in the target position with interference fit to generate a support force, the leaflet segment 20 does not need to be It completely fits the target position, so the leaflet segment 20 provided with the leaflet 200 is not easily affected by the shape of the target position, and the leaflet segment 20 can maintain the original shape, thereby avoiding the problems of insufficiency and excessive central regurgitation.
再次参看图1,阻流膜300包括第一阻流膜301和第二阻流膜302,第一阻流膜301和第二阻流膜302拼接在一起,其中第一阻流膜301设置在瓣叶段20,第二阻流膜302设置在过渡段30。瓣叶段20的最大直径尺寸小于过渡段30的最大直径尺寸,因此,就算瓣叶段20没有完全贴合目标位置,只要保证过渡段30能够完全贴合目标位置,设置在过渡段30的第二阻流膜302能够有效地阻止血液的渗透。1 again, the blocking film 300 includes a first blocking film 301 and a second blocking film 302, the first blocking film 301 and the second blocking film 302 are spliced together, wherein the first blocking film 301 is disposed on the In the leaflet segment 20 , the second flow blocking membrane 302 is disposed on the transition segment 30 . The maximum diameter dimension of the valve leaflet segment 20 is smaller than the maximum diameter dimension of the transition segment 30. Therefore, even if the valve leaflet segment 20 does not completely fit the target position, as long as the transition segment 30 can be fully fitted to the target position, it is arranged at the first position of the transition segment 30. The second flow blocking membrane 302 can effectively prevent the penetration of blood.
本实施方式的阻流膜300通过缝合线固定连接在瓣膜支架100上,例如设置在瓣膜支架100的内表面或外表面,阻流膜300覆盖了瓣膜支架100的瓣叶段20和过渡段30,阻流膜的作用主要起固定瓣叶200和阻止血液从瓣叶200的自由边220形成的通道以外区域流动。其中瓣叶段20的第一阻流膜301可采用与扩张后的瓣膜支架100的内表面形状相同尺寸的圆筒布,并且第一阻流膜301中未与第二阻流膜302连接的一端的轮廓可根据瓣膜支架100或者瓣叶200的固定边的边缘形状进行修剪或直接采用平口。过渡段30的第二阻流膜302可采用与扩张后的过渡段30结构相同尺寸的管状布直接缝合,也可以通过数个扇形结构小片拼接缝合组成,过渡段30的第二阻流膜302可更有效的防止周边泄露。阻流膜300的缝合均在扩张后的瓣膜支架100的自然状态下进行,在不影响瓣膜支架100形态下保持阻流膜300的表面紧致。瓣叶段20的第一阻流膜301和过渡段30的第二阻流膜302的材料可不同也可相同。缝合线的材料优选高分子材料,如PET、PTFE、PU等。The blocking membrane 300 of this embodiment is fixedly connected to the valve stent 100 by sutures, for example, is disposed on the inner surface or the outer surface of the valve stent 100 , and the blocking membrane 300 covers the valve leaflet section 20 and the transition section 30 of the valve stent 100 . , the function of the baffle film is mainly to fix the valve leaflet 200 and prevent the blood from flowing from the area outside the channel formed by the free edge 220 of the valve leaflet 200 . The first blocking membrane 301 of the valve leaflet segment 20 can be made of a cylindrical cloth with the same size as the inner surface shape of the expanded valve stent 100, and the first blocking membrane 301 is not connected to the second blocking membrane 302. The contour of one end can be trimmed according to the shape of the edge of the fixed side of the valve support 100 or the valve leaflet 200, or a flat mouth can be used directly. The second flow blocking membrane 302 of the transition section 30 can be directly sewed with a tubular cloth of the same size as the expanded transition section 30 structure, or can be formed by splicing and stitching several fan-shaped small pieces. The second flow blocking membrane 302 of the transition section 30 It can more effectively prevent peripheral leakage. The suturing of the blocking membrane 300 is performed in the natural state of the expanded valve stent 100 , and the surface of the blocking membrane 300 is kept compact without affecting the shape of the valve stent 100 . The materials of the first flow blocking membrane 301 of the leaflet segment 20 and the second flow blocking membrane 302 of the transition section 30 may be different or the same. The material of the suture is preferably a polymer material, such as PET, PTFE, PU and the like.
参看图3,瓣叶段20为多个瓦片状结构单元21组成的管状结构,在瓣膜支架100的收缩状态和扩张状态的切换过程中,瓦片状结构单元21上任意轴向共线的两点间的轴向长度保持不变。Referring to FIG. 3 , the valve leaflet segment 20 is a tubular structure composed of a plurality of tile-shaped structural units 21 . During the switching process between the contracted state and the expanded state of the valve stent 100 , any axially collinear portion of the tile-shaped structural unit 21 The axial length between the two points remains the same.
通过将瓣叶段20设计为多个瓦片状结构单元21组成的管状结构,且在瓣膜支架100的收缩状态和扩张状态的切换过程中,瓦片状结构单元21上任意轴向共线的两点间的轴向长度保持不变,从而有利于防止固定在瓣叶段20上的瓣叶200和阻流膜300因瓣膜支架100在入鞘收缩过程中发生轴向变形而受到轴向拉力,进而有效地防止阻流膜和瓣叶200因撕裂而导致瓣膜支架100发生泄 漏的问题。By designing the valve leaflet segment 20 as a tubular structure composed of a plurality of tile-like structural units 21, and in the process of switching between the contracted state and the expanded state of the valve stent 100, any axially collinear on the tile-like structural units 21 The axial length between the two points remains unchanged, which is beneficial to prevent the valve leaflet 200 and the blocking membrane 300 fixed on the valve leaflet segment 20 from being subjected to axial tension due to the axial deformation of the valve stent 100 during the process of sheathing and shrinking. , thereby effectively preventing the valve stent 100 from leaking due to tearing of the flow blocking membrane and the valve leaflets 200 .
结合图3至图5所示,本实施方式中瓣叶段20的多个瓦片状结构单元21沿瓣叶段20的周向方向和轴向方向顺序排列。其中,瓦片状结构单元21包括两个V型连杆211和两个直杆212。两个V型连杆211沿瓣叶段20的轴向方向间隔设置,且两个V型连杆211的开口方向一致。两个直杆212沿瓣叶段20的周向方向间隔设置,两个V型连杆211通过两个直杆212相连。其中,V型连杆211由两段曲杆连接而成,两段曲杆的连接处形成第一端点A。每个V型连杆211的两端固定在周向均匀分布的相邻直杆212上,直杆212的数量为瓣叶200数量的整数倍,优选为12根直杆212,从而对瓣叶200进行有效的支撑,并在瓣叶段20受挤压变形的过程中,保持周向各位置的变形一致。轴向上,周向分布的V型连杆211采用等距阵列,阵列数量大于等于2,阵列的间距大于曲杆上两端点间的距离,即直杆212的长度大于V型连杆211在瓣叶段20的轴向方向上的最大长度,优选阵列数量为3排,从而保证瓣叶段20受挤压变形的过程中,V型连杆211在轴向方向上具有足够的变形空间,防止轴向方向上相邻设置的两个V型连杆211间相互挤压,从而造成阻流膜和瓣叶200的撕裂,进而导致瓣膜支架100发生泄漏的问题。With reference to FIGS. 3 to 5 , in this embodiment, the plurality of tile-shaped structural units 21 of the valve leaflet segment 20 are sequentially arranged along the circumferential direction and the axial direction of the valve leaflet segment 20 . The tile-shaped structural unit 21 includes two V-shaped connecting rods 211 and two straight rods 212 . The two V-shaped links 211 are arranged at intervals along the axial direction of the leaflet segment 20 , and the opening directions of the two V-shaped links 211 are the same. The two straight rods 212 are arranged at intervals along the circumferential direction of the leaflet segment 20 , and the two V-shaped links 211 are connected by the two straight rods 212 . Wherein, the V-shaped connecting rod 211 is formed by connecting two sections of curved rods, and the first end point A is formed at the connection of the two sections of curved rods. Both ends of each V-shaped link 211 are fixed on adjacent straight rods 212 evenly distributed in the circumferential direction. The valve 200 is effectively supported, and in the process of the valve leaflet segment 20 being squeezed and deformed, the deformation of each position in the circumferential direction is kept consistent. In the axial direction, the circumferentially distributed V-shaped connecting rods 211 adopt an equidistant array, the number of arrays is greater than or equal to 2, and the spacing of the arrays is greater than the distance between the two ends of the curved rod, that is, the length of the straight rod 212 is greater than that of the V-shaped connecting rod 211. The maximum length in the axial direction of the leaflet segment 20 is preferably 3 rows, so as to ensure that the V-shaped link 211 has sufficient deformation space in the axial direction during the process of the leaflet segment 20 being squeezed and deformed. The two V-shaped connecting rods 211 disposed adjacent to each other in the axial direction are prevented from being pressed against each other, thereby causing tearing of the flow blocking membrane and the valve leaflets 200 , thereby causing leakage of the valve stent 100 .
再结合图4和图5所示,瓦片状结构单元21在收缩状态和扩张状态间切换时,在切换过程中直杆212未发生变形,仍保留轴向的竖直状态。V型连杆211发生变形,由于两V型连杆211的结构一致,所以在瓦片状结构单元21的状态切换过程中始终保持同步变形,两V型连杆211间的轴向距离始终保持一致,从而保证瓦片状结构单元21内任意轴向共线的两点间的距离在瓣膜支架100的扩张状态和收缩状态切换时将保持不变。4 and 5 again, when the tile-shaped structural unit 21 is switched between the contracted state and the expanded state, the straight rod 212 is not deformed during the switching process, and still retains the vertical state in the axial direction. The V-shaped link 211 is deformed. Since the structures of the two V-shaped links 211 are the same, the synchronous deformation is always maintained during the state switching process of the tile-shaped structural unit 21, and the axial distance between the two V-shaped links 211 is always maintained. In order to ensure that the distance between any axially collinear two points in the tile-shaped structural unit 21 will remain unchanged when the valve stent 100 is switched between the expanded state and the contracted state.
再如图3所示,在本发明的一些实施方式中,瓣叶段20还包括瓣叶框40。瓣叶框40设置在的瓣叶段20中不与过渡段30连接的一端,具体地,瓣叶框40等距离间隔地设置在直杆212上,在本实施例中,瓣叶框40设置在与瓣叶200的数量相等的等间隔设置的直杆212上,瓣叶框用于固定瓣叶200的瓣角。瓣叶框40的内部设有一长方形的中空结构,用于固定瓣叶200的瓣角。本实施方式的瓣膜支架100还包括连接部50,连接部50与瓣叶框40的端部相连接,瓣叶框40设置在连接部50与直杆212之间。连接部50为T字型结构,连接部 50用于在输送过程中连接瓣膜支架100和输送器。As also shown in FIG. 3 , in some embodiments of the present invention, the leaflet segment 20 further includes a leaflet frame 40 . The leaflet frame 40 is disposed at the end of the leaflet segment 20 that is not connected to the transition segment 30. Specifically, the leaflet frame 40 is arranged on the straight rod 212 at equal intervals. In this embodiment, the leaflet frame 40 is provided with The leaflet frame is used to fix the valve angle of the leaflet 200 on the straight rods 212 that are equally spaced as the number of leaflets 200 . The inside of the leaflet frame 40 is provided with a rectangular hollow structure for fixing the valve angle of the leaflet 200 . The valve stent 100 of the present embodiment further includes a connecting portion 50 . The connecting portion 50 is connected to the end of the leaflet frame 40 , and the leaflet frame 40 is disposed between the connecting portion 50 and the straight rod 212 . The connecting portion 50 is a T-shaped structure, and the connecting portion 50 is used to connect the valve stent 100 and the delivery device during the delivery process.
如图6所示,本实施方式的支撑段10在扩张状态下整体呈管状结构,包括多个支撑杆11,多个支撑杆11间通过支撑段连接点B进行相连并构成周向的封闭形状。每个支撑杆11首尾通过支撑段连接点B进行连接构成菱形结构单元,菱形结构单元绕支撑段10的轴线周向均匀阵列分布,优选阵列数量为瓣叶段20的直杆212数量的整数倍。然后通过蜂窝结构设计轴向的第二层、第三层甚至更多层。本实施方式中,考虑瓣膜支架100的整体长度不宜过长,优选支撑段10共有两层菱形结构单元。支撑段10采用菱形结构单元可以保证在压缩至较小直径时仍可以提供足够的径向支撑力。As shown in FIG. 6 , the support section 10 of the present embodiment has a tubular structure as a whole in an expanded state, and includes a plurality of support rods 11 , and the plurality of support rods 11 are connected through the support section connection point B to form a circumferential closed shape . The head and tail of each support rod 11 are connected through the support section connection point B to form a diamond-shaped structural unit. The diamond-shaped structural units are distributed in a uniform array around the axis of the support section 10 , and the number of arrays is preferably an integer multiple of the number of straight rods 212 of the leaflet section 20 . The second, third and even more layers in the axial direction are then designed through the honeycomb structure. In this embodiment, considering that the overall length of the valve stent 100 should not be too long, it is preferable that the support section 10 has two layers of diamond-shaped structural units. The use of diamond-shaped structural units for the support section 10 can ensure that sufficient radial support force can still be provided when compressed to a smaller diameter.
再如图7所示,过渡段30在扩张状态下整体呈近端大远端小的管状结构。过渡段30包括多个第一连杆31和多个第二连杆32,第一连杆31的一端与第二连杆32的一端连接,形成过渡段连接节点C,第一连杆31的另一端与瓣叶段20相连,第二连杆32的另一端与支撑段10相连,在过渡段30上形成至少一开放结构单元303,多个开放结构单元303周向排列形成过渡段30。在本实施例中,两个第一连杆31与两个第二连杆32形成“X”形的开放结构单元303,第一连杆31的长度大于第二连杆32的长度,第二连杆32的长度与支撑杆11的长度大致相等,从而使周向方向上任意相邻的两个第一连杆31间的间距大于周向方向上任意相邻的两个第二连杆32间的间距,保证过渡段30具有较好的可压缩性。同时,过渡段连接节点C的数量小于支撑段10上同一圆周方向的支撑段连接点B的数量,支撑段连接点B的数量是过渡段连接节点C的数量的整数倍。过渡段30上周向方向上端点数量的减小可降低瓣膜支架100的径向刚度,能够有效的阻隔支撑段10向瓣叶段20传递径向力。As shown in FIG. 7 , in the expanded state, the transition section 30 has a tubular structure with a large proximal end and a small distal end as a whole. The transition section 30 includes a plurality of first connecting rods 31 and a plurality of second connecting rods 32. One end of the first connecting rod 31 is connected with one end of the second connecting rod 32 to form a connecting node C of the transition section. The other end is connected to the leaflet segment 20 , and the other end of the second link 32 is connected to the support segment 10 . In this embodiment, the two first links 31 and the two second links 32 form an "X"-shaped open structure unit 303 , the length of the first links 31 is greater than the length of the second links 32 , and the second The length of the connecting rod 32 is approximately equal to the length of the support rod 11, so that the distance between any two adjacent first connecting rods 31 in the circumferential direction is greater than any two adjacent second connecting rods 32 in the circumferential direction. The distance between them ensures that the transition section 30 has better compressibility. Meanwhile, the number of transition section connection nodes C is less than the number of support section connection points B in the same circumferential direction on the support section 10 , and the number of support section connection points B is an integer multiple of the number of transition section connection nodes C. The reduction in the number of end points in the circumferential direction of the transition section 30 can reduce the radial stiffness of the valve stent 100 , and can effectively prevent the support section 10 from transmitting radial force to the valve leaflet section 20 .
再结合图1和图3所示,本实施方式的瓣叶段20的近端还设有沿轴向方向设置的连接杆22,连接杆22设于相邻设置的两个瓦片状结构单元21之间,第一连杆31的一端通过连接杆22与瓣叶段20的近端相连,第一连杆31的另一端通过过渡段连接节点C与第二连杆32的一端相连,第二连杆32的另一端通过支撑段连接点B与支撑段10的远端相连。过渡段30设置开放结构单元303,使本身不形成封闭结构的单元,使过渡段30具有较弱的径向刚度,使连接在过渡段30两端的支撑段10和瓣叶段20能够相互不受影响,从而有利于阻隔支撑 段10向瓣叶段20的径向力传递,使得在释放过程中,可以先完全释放瓣叶段20或支撑段10,而保留另一段在输送鞘内,有利于在使用过程中选择最合适状态进行释放,降低操作难度。瓣膜支架100采用合金管材激光切割而成,材料优选超弹性镍钛合金和不锈钢材料,后续通过热处理扩张定型及表面处理,达到要求的设计形状、尺寸及表面质量。1 and 3 again, the proximal end of the valve leaflet segment 20 in this embodiment is further provided with a connecting rod 22 arranged in the axial direction, and the connecting rod 22 is provided on two adjacent tile-shaped structural units. 21, one end of the first connecting rod 31 is connected to the proximal end of the valve leaflet segment 20 through the connecting rod 22, the other end of the first connecting rod 31 is connected to one end of the second connecting rod 32 through the transition section connecting node C, The other end of the second link 32 is connected to the distal end of the support section 10 through the support section connecting point B. The transition section 30 is provided with an open structural unit 303, so that it does not form a closed structure unit, so that the transition section 30 has a weaker radial rigidity, so that the support section 10 and the leaflet section 20 connected at both ends of the transition section 30 can not be affected by each other. Therefore, it is beneficial to block the radial force transmission from the support segment 10 to the valve leaflet segment 20, so that during the release process, the valve leaflet segment 20 or the support segment 10 can be completely released first, while the other segment is retained in the delivery sheath, which is beneficial to Choose the most suitable state to release during use to reduce the difficulty of operation. The valve stent 100 is made of an alloy tube by laser cutting, and the material is preferably superelastic nickel-titanium alloy and stainless steel, and is subsequently expanded, shaped and surface treated by heat treatment to achieve the required design shape, size and surface quality.
通过将瓣膜支架100上的瓣叶段20和支撑段10分开设置,并在瓣叶段20和支撑段10之间设有缓冲作用的过渡段30,可有效地减小在瓣膜支架100的收缩变形过程中由支撑段10向瓣叶段30传递的径向力,以实现更大程度地保留瓣叶200部位圆形截面的理想工作状态。同时,瓣膜支架100的过渡段30采用刚度较低的结构(开放结构单元),在瓣膜支架100的释放过程中,可以先完全释放瓣叶段20或支撑段10,而保留另一段在输送鞘内,有利于在使用过程中选择最合适状态进行释放,降低操作难度。By arranging the valve leaflet segment 20 and the support segment 10 separately on the valve support 100, and providing a buffering transition segment 30 between the valve leaflet segment 20 and the support segment 10, the shrinkage of the valve support 100 can be effectively reduced The radial force transmitted by the support segment 10 to the valve leaflet segment 30 during the deformation process can achieve the ideal working state of retaining the circular cross-section of the valve leaflet 200 to a greater extent. At the same time, the transition section 30 of the valve stent 100 adopts a structure with lower rigidity (open structural unit). During the release process of the valve stent 100, the valve leaflet section 20 or the support section 10 can be completely released first, while the other section is retained in the delivery sheath. It is beneficial to select the most suitable state for release during use, reducing the difficulty of operation.
结合图1和图8所示,本实施方式的人工心脏瓣膜1000共设有3个瓣叶200,瓣叶200的结构和形状均相同,首尾通过瓣角230相连并均匀分布在瓣膜支架100的内部。瓣叶200包括固定边210和自由边220,其中固定边210通过缝合线固定在瓣叶段20的阻流膜上,自由边220不做约束,可呈角度的开合。瓣角230从瓣叶段20的瓣叶框40由内向外穿出,然后绕过瓣叶框40上的杆向外翻折回与瓣膜支架100内的瓣叶200相贴合,并使用缝合线进行固定。1 and FIG. 8 , the artificial heart valve 1000 of this embodiment is provided with three leaflets 200 in total. The structure and shape of the leaflets 200 are the same. internal. The valve leaflet 200 includes a fixed edge 210 and a free edge 220, wherein the fixed edge 210 is fixed on the blocking membrane of the valve leaflet segment 20 by sutures, and the free edge 220 is not constrained and can be opened and closed at an angle. The valve angle 230 passes through the leaflet frame 40 of the leaflet segment 20 from the inside to the outside, and then goes around the rod on the leaflet frame 40 and folds back outward to fit the valve leaflet 200 in the valve support 100, and use sutures to be fixed.
在本发明的其他实施方式中,瓣膜支架100的过渡段30的结构与上述实施方式不同。如图9所示,在该实施方式中,过渡段30由多个沿周向方向间隔设置的第三连杆33组成,第三连杆33可以是简单的直杆。第三连杆33的远端与瓣叶段20近端的第一端点A相连,第三连杆33的近端与支撑段10远端的支撑段连接点B相连。第三连杆33在经瓣膜支架的中心轴线O的平面上的投影与瓣膜支架的中心轴线O平行或者重合。In other embodiments of the present invention, the structure of the transition section 30 of the valve stent 100 is different from the above-mentioned embodiments. As shown in FIG. 9 , in this embodiment, the transition section 30 is composed of a plurality of third connecting rods 33 spaced in the circumferential direction, and the third connecting rods 33 may be simple straight rods. The distal end of the third link 33 is connected to the first end point A of the proximal end of the valve leaflet segment 20 , and the proximal end of the third link 33 is connected to the support segment connection point B at the distal end of the support segment 10 . The projection of the third link 33 on the plane of the central axis O of the valve stent is parallel to or coincident with the central axis O of the valve stent.
在上述实施方式中,通过第三连杆33代替第一连杆31和第二连杆32,取消了过渡段30上过渡段连接节点C的存在,从而降低了过渡段30的径向刚度,进而有利于阻隔支撑段10向瓣叶段20传递径向力。可以理解的,开放结构单元包括第三连杆33,第三连杆33在过渡段30上的设置方式,形成了过渡段30上的开放结构单元。In the above embodiment, by replacing the first link 31 and the second link 32 with the third link 33, the existence of the transition section connecting node C on the transition section 30 is eliminated, thereby reducing the radial stiffness of the transition section 30, In turn, it is beneficial to block the transmission of radial force from the support segment 10 to the leaflet segment 20 . It can be understood that the open structural unit includes the third connecting rod 33 , and the arrangement of the third connecting rod 33 on the transition section 30 forms an open structural unit on the transition section 30 .
在本申请的其他实施方式中,还可对第三连杆33的结构进行变形。第三连杆33在与过渡段30表面相切的平面的投影为直线形、弧线形或折线形中的任一种,或者为直线形、弧线形或折线形中至少两种的组合。结合图10至图14所示,第三连杆33在与过渡段30的表面相切的平面的投影可以是弧线段、带有角度的多杆段、带有波圈的曲线段、带有多个S型弯折的弯杆段或带有破折号形状的多杆段中的任一种。通过在第三连杆33上设置各种弯折结构,能够使第三连杆33在轴向上等效增加了一个弹性件,降低了第三连杆33自身的刚度,从而降低了过渡段30的径向刚度,进而有利于阻隔支撑段10向瓣叶段20传递径向力。In other embodiments of the present application, the structure of the third link 33 may also be modified. The projection of the third link 33 on the plane tangent to the surface of the transition section 30 is any one of a straight line, an arc shape or a broken line shape, or a combination of at least two of the straight line, arc shape or broken line shape . 10 to 14 , the projection of the third link 33 on a plane tangent to the surface of the transition section 30 may be an arc segment, a multi-rod segment with an angle, a curved segment with a wave circle, a belt Either a bent bar segment with multiple S-bends or a multi-bar segment with a dash shape. By arranging various bending structures on the third connecting rod 33, an elastic member can be added to the third connecting rod 33 in the axial direction, which reduces the rigidity of the third connecting rod 33 itself, thereby reducing the transition section. The radial stiffness of 30 is favorable for blocking the transmission of radial force from the support segment 10 to the leaflet segment 20 .
再如图15所示,在本申请的其他实施方式中,第三连杆33在经瓣膜支架的中心轴线O的平面上的投影与瓣膜支架的中心轴线O相交并形成夹角,也就是将第三连杆33在轴向上倾斜设置。通过将第三连杆33在轴向上倾斜设置,使得瓣膜支架100在受力时可通过扭转来缓解压力,从而降低了过渡段30的径向刚度,进而有利于阻隔支撑段10向瓣叶段20传递径向力。As shown in FIG. 15 , in other embodiments of the present application, the projection of the third link 33 on the plane of the central axis O of the transvalvular stent intersects and forms an included angle with the central axis O of the valve stent, that is, the The third link 33 is inclined in the axial direction. By slanting the third connecting rod 33 in the axial direction, the valve stent 100 can be twisted to relieve the pressure when it is under force, thereby reducing the radial stiffness of the transition section 30, thereby facilitating the blocking of the support section 10 from the valve leaflet. Segment 20 transmits radial forces.
在本申请的其他实施方式中,过渡段30与瓣叶段20和/或支撑段10采用分体式的结构设计,即过渡段30以可拆卸的方式与瓣叶段20和/或支撑段10相连。结合图16和图17所示,该实施方式的瓣叶段20的一端、第三连杆33的两端以及支撑段10的一端均设有安装孔,第三连杆33的一端通过扣环60穿过安装孔与瓣叶段20的一端相连,第三连杆33的另一端通过扣环60穿过安装孔与支撑段10的一端相连,从而将第三连杆33的两端分别与第一端点A和支撑段连接点B相独立,避免由支撑段10在支撑段连接点B上产生的扭矩的传递,进而减小对瓣叶段20的变形影响。In other embodiments of the present application, the transition segment 30 and the valve leaflet segment 20 and/or the support segment 10 adopt a split structure design, that is, the transition segment 30 is detachably connected to the valve leaflet segment 20 and/or the support segment 10 in a detachable manner. connected. 16 and 17 , in this embodiment, one end of the leaflet segment 20 , both ends of the third link 33 and one end of the support segment 10 are provided with mounting holes, and one end of the third link 33 passes through a retaining ring 60 is connected to one end of the leaflet segment 20 through the mounting hole, and the other end of the third link 33 is connected to one end of the support segment 10 through the retaining ring 60 through the mounting hole, so that the two ends of the third link 33 are respectively connected to the one end of the support segment 10. The first end point A is independent of the connection point B of the support segment, so as to avoid the transmission of torque generated by the support segment 10 at the connection point B of the support segment, thereby reducing the influence on the deformation of the leaflet segment 20 .
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以权利要求的保护范围为准。The above description is only a preferred embodiment of the present invention, but the protection scope of the present invention is not limited to this. Substitutions should be covered within the protection scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.

Claims (10)

  1. 一种瓣膜支架,其特征在于,所述瓣膜支架呈管状结构,所述瓣膜支架包括支撑段、过渡段和瓣叶段,所述过渡段用于连接所述支撑段和所述瓣叶段,所述瓣叶段用于设置瓣叶,所述支撑段用于支撑所述瓣膜支架,所述瓣叶段的最大直径尺寸小于所述过渡段的最大直径,所述过渡段的最大直径小于或等于所述支撑段的最大直径尺寸,其中,所述过渡段包括若干连杆,所述连杆在所述过渡段上形成至少一开放结构单元。A valve support, characterized in that the valve support has a tubular structure, the valve support includes a support section, a transition section and a valve leaflet section, and the transition section is used to connect the support section and the valve leaflet section, The valve leaflet segment is used to set the valve leaflet, the support segment is used to support the valve support, the maximum diameter of the valve leaflet segment is smaller than the maximum diameter of the transition segment, and the maximum diameter of the transition segment is smaller than or It is equal to the largest diameter dimension of the support section, wherein the transition section includes several connecting rods, and the connecting rods form at least one open structural unit on the transition section.
  2. 根据权利要求1所述的瓣膜支架,其特征在于,所述过渡段的径向刚度均小于所述支撑段的径向刚度和所述瓣叶段的径向刚度中最小的径向刚度。The valve stent according to claim 1, wherein the radial stiffness of the transition section is smaller than the smallest radial stiffness among the radial stiffness of the support section and the radial stiffness of the valve leaflet section.
  3. 根据权利要求1所述的瓣膜支架,其特征在于,所述开放结构单元包括第一连杆和第二连杆,所述第一连杆的一端与所述第二连杆的一端连接,形成过渡段连接节点,所述第一连杆的另一端与所述瓣叶段相连,所述第二连杆的另一端与所述支撑段相连。The valve stent according to claim 1, wherein the open structural unit comprises a first connecting rod and a second connecting rod, and one end of the first connecting rod is connected with one end of the second connecting rod to form a The transition segment is connected to a node, the other end of the first link is connected to the leaflet segment, and the other end of the second link is connected to the support segment.
  4. 根据权利要求3所述的瓣膜支架,其特征在于,所述支撑段包括若干支撑杆,所述支撑杆相互连接,形成支撑段连接点,所述过渡段连接节点的数量少于所述支撑段连接点的数量。The valve stent according to claim 3, wherein the support section includes a plurality of support rods, the support rods are connected to each other to form support section connection points, and the number of connection nodes of the transition section is less than that of the support section The number of connection points.
  5. 根据权利要求1所述的瓣膜支架,其特征在于,所述开放结构单元包括第三连杆,多个所述第三连杆沿所述过渡段的周向方向间隔设置,所述第三连杆的一端与所述瓣叶段相连,所述第三连杆的另一端与所述支撑段相连。The valve support according to claim 1, wherein the open structural unit comprises a third connecting rod, a plurality of the third connecting rods are arranged at intervals along the circumferential direction of the transition section, and the third connecting rods are arranged at intervals along the circumferential direction of the transition section. One end of the rod is connected to the leaflet segment, and the other end of the third link is connected to the support segment.
  6. 根据权利要求5所述的瓣膜支架,其特征在于,所述第三连杆在经所述瓣膜支架的中心轴线的平面上的投影与所述瓣膜支架的中心轴线相交并形成夹角。The valve holder according to claim 5, wherein the projection of the third link on a plane passing through the central axis of the valve holder intersects and forms an included angle with the central axis of the valve holder.
  7. 根据权利要求5所述的瓣膜支架,其特征在于,所述第三连杆在经所述瓣膜支架的中心轴线的平面上的投影与所述瓣膜支架的中心轴线平行或者重 合。The valve holder according to claim 5, wherein the projection of the third link on a plane passing through the central axis of the valve holder is parallel to or coincident with the central axis of the valve holder.
  8. 根据权利要求5所述的瓣膜支架,其特征在于,所述第三连杆在与所述过渡段表面相切的平面的投影为直线形、弧线形或折线形中的任一种,或者为直线形、弧线形或折线形中至少两种的组合。The valve support according to claim 5, wherein the projection of the third link on a plane tangent to the surface of the transition section is any one of a straight line, an arc, or a broken line, or It is a combination of at least two of straight line, arc or polyline.
  9. 根据权利要求1所述的瓣膜支架,其特征在于,所述过渡段与所述支撑段间以可拆卸的方式相连,和/或所述过渡段与所述瓣叶段之间以可拆卸的方式相连。The valve support according to claim 1, wherein the transition section and the support section are connected in a detachable manner, and/or the transition section and the valve leaflet section are detachably connected way connected.
  10. 一种人工心脏瓣膜,其特征在于,具有根据权利要求1至9中任一项所述的瓣膜支架,还包括:An artificial heart valve, characterized in that it has the valve support according to any one of claims 1 to 9, further comprising:
    阻流膜,所述阻流膜设于所述瓣叶段和所述过渡段;A choke film, the choke film is arranged on the valve leaflet segment and the transition segment;
    多个瓣叶,所述瓣叶包括固定边和自由边,所述固定边固定连接于所述瓣叶段,所述自由边呈角度的开合。A plurality of valve leaflets, the valve leaflet includes a fixed edge and a free edge, the fixed edge is fixedly connected to the valve leaflet segment, and the free edge is opened and closed at an angle.
PCT/CN2021/101409 2020-08-20 2021-06-22 Valve stent and prosthetic heart valve WO2022037242A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010844950.8 2020-08-20
CN202010844950.8A CN114073603B (en) 2020-08-20 2020-08-20 Valve support and artificial heart valve

Publications (1)

Publication Number Publication Date
WO2022037242A1 true WO2022037242A1 (en) 2022-02-24

Family

ID=80282097

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/101409 WO2022037242A1 (en) 2020-08-20 2021-06-22 Valve stent and prosthetic heart valve

Country Status (2)

Country Link
CN (1) CN114073603B (en)
WO (1) WO2022037242A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115177411A (en) * 2022-07-22 2022-10-14 启晨(上海)医疗器械有限公司 Bronchus valve

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116999207A (en) * 2022-04-29 2023-11-07 上海微创心通医疗科技有限公司 Valve stent, valve prosthesis and valve prosthesis system
CN116999208A (en) * 2022-04-29 2023-11-07 上海微创心通医疗科技有限公司 valve prosthesis
CN117618160B (en) * 2024-01-11 2024-04-09 北京迈迪顶峰医疗科技股份有限公司 Valve stent, processing method of valve stent and artificial valve

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222674A1 (en) * 2004-03-31 2005-10-06 Med Institute, Inc. Endoluminal graft with a prosthetic valve
CN101953728A (en) * 2010-04-19 2011-01-26 杭州启明医疗器械有限公司 Conveniently-implantable artificial valve replacement device and scaffold
CN109549760A (en) * 2017-09-26 2019-04-02 启铭医疗器械(上海)有限公司 A kind of valve bracket reducing reduction length
CN208864574U (en) * 2017-12-20 2019-05-17 乐普(北京)医疗器械股份有限公司 It can position recyclable through conduit implanted aorta petal film device
CN209499982U (en) * 2018-10-23 2019-10-18 中国医学科学院阜外医院 It is a kind of through surgical implantation aorta exempt from suture biovalve

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485141B2 (en) * 2002-05-10 2009-02-03 Cordis Corporation Method of placing a tubular membrane on a structural frame
US8425593B2 (en) * 2007-09-26 2013-04-23 St. Jude Medical, Inc. Collapsible prosthetic heart valves
US9480557B2 (en) * 2010-03-25 2016-11-01 Medtronic, Inc. Stents for prosthetic heart valves
CN101961273B (en) * 2010-04-19 2012-11-21 杭州启明医疗器械有限公司 Valvular prosthetic replacement device with buffer action and stent
EP3001978B2 (en) * 2010-09-23 2023-03-01 Edwards Lifesciences CardiAQ LLC Replacement heart valve delivery device
CN203029425U (en) * 2012-11-30 2013-07-03 宁波健世生物科技有限公司 Support with valve
US20150057747A1 (en) * 2013-08-22 2015-02-26 St. Jude Medical, Cardiology Division, Inc. Stent with alternative cell shapes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222674A1 (en) * 2004-03-31 2005-10-06 Med Institute, Inc. Endoluminal graft with a prosthetic valve
CN101953728A (en) * 2010-04-19 2011-01-26 杭州启明医疗器械有限公司 Conveniently-implantable artificial valve replacement device and scaffold
CN109549760A (en) * 2017-09-26 2019-04-02 启铭医疗器械(上海)有限公司 A kind of valve bracket reducing reduction length
CN208864574U (en) * 2017-12-20 2019-05-17 乐普(北京)医疗器械股份有限公司 It can position recyclable through conduit implanted aorta petal film device
CN209499982U (en) * 2018-10-23 2019-10-18 中国医学科学院阜外医院 It is a kind of through surgical implantation aorta exempt from suture biovalve

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115177411A (en) * 2022-07-22 2022-10-14 启晨(上海)医疗器械有限公司 Bronchus valve

Also Published As

Publication number Publication date
CN114073603B (en) 2023-05-02
CN114073603A (en) 2022-02-22

Similar Documents

Publication Publication Date Title
WO2022037242A1 (en) Valve stent and prosthetic heart valve
US11173032B2 (en) Transcatheter device for treating mitral regurgitation
US20220008195A1 (en) Docking elements
US20210338427A1 (en) Axisymmetric adjustable device for treating mitral regurgitation
US10398546B2 (en) Mitral prosthesis and methods for implantation
US10743991B2 (en) Chordae tendineae adjustment
US6726716B2 (en) Self-molding annuloplasty ring
US8052751B2 (en) Annuloplasty rings for repairing cardiac valves
US20200069419A1 (en) Device for treatment of valve regurgitation
US20050004665A1 (en) Annuloplasty rings and methods for repairing cardiac valves
US20030045929A1 (en) Tricuspid ring and template
WO2009111241A2 (en) Catheter deliverable artificial multi-leaflet heart valve prosthesis and intravascular delivery system for a catheter deliverable heart valve prosthesis
CN114028030B (en) Artificial heart valve
US20210113332A1 (en) Invertible valve support frame for use with prosthetic heart valve apparatus
US20210298896A1 (en) Prosthetic hemi heart valve
CN216168093U (en) Prosthetic heart valve prosthesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21857338

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21857338

Country of ref document: EP

Kind code of ref document: A1